GLO1 and type 2 diabetes mellitus: In addition, in the plasma of T2DM patients, metformin, through its guanidine group, was shown to bind to MGO, reducing this dicarbonyl concentration [18], hence reducing AGEs formation, which paralleled a significant increase in Glo1 activity [217].